| Christopher A Masi, MD | |
|
600 Round Rock West Drive, Suite 504, Round Rock, TX 78681 | |
| (512) 502-5696 | |
| (512) 502-5704 |
| Full Name | Christopher A Masi |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 600 Round Rock West Drive, Round Rock, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053536128 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | J4329 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher A Masi, MD 600 Round Rock West Drive, Suite 504, Round Rock, TX 78681 Ph: (512) 502-5696 | Christopher A Masi, MD 600 Round Rock West Drive, Suite 504, Round Rock, TX 78681 Ph: (512) 502-5696 |
News Archive
Vortioxetine (trade name: Brintellix) has been approved since December 2013 for the treatment of depression in adults, but did not become actually available before May 2015. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this drug offers an added benefit over the appropriate comparator therapy. Such an added benefit cannot be derived from the dossier because it contained no data evaluable for the assessment.
People who live in walkable communities are more civically involved and have greater levels of trust than those who live in less walkable neighborhoods. And this increase in so-called 'social capital' is associated with higher quality of life, according to Shannon Rogers and her team from the University of New Hampshire in the US. Their research, looking at the social benefits of walkability in communities, is published online in Springer's journal Applied Research in Quality of Life.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
A team of neurobiologists from Peter the Great St. Petersburg Polytechnic University published an article on their study of the causes of Alzheimer's disease and suggested therapy methods.
› Verified 1 days ago
Dr. Jeffrey Jasper Tramonte, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 300 University Blvd Bldg A, Round Rock, TX 78665 Phone: 512-509-0200 | |
Ms. Luanne Taylor, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1009 N Georgetown St, Round Rock, TX 78664 Phone: 512-244-8374 Fax: 512-244-8371 | |
Mr. John L. Troutner, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-8404 Fax: 512-509-5328 | |
Dr. Michael Musgrove, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1201 Sam Bass Rd, Round Rock, TX 78681 Phone: 512-964-6992 Fax: 512-388-0373 | |
Dr. Elizabeth Anne Calvin, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1009 N Georgetown St, Round Rock, TX 78664 Phone: 512-255-1720 | |
Ms. Kerri Ann Halfant, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1009 N Georgetown St, Round Rock, TX 78664 Phone: 512-244-8374 Fax: 512-244-8371 |